AllNewsPhotosVideos
Serum Institute of India

Serum Institute Of India Private Ltd.

Serum institute of india private ltd., Latest News

Serum Institute of India is an Indian biotechnology and biopharmaceuticals company. It is the world's largest vaccine manufacturer. It is located in the city of Pune, Maharashtra, India, and was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Poonawalla Investment and Industries.
Read More
India's decision to resume COVID-19 vaccine export to have immense positive impact: GAVI - Hindi News | India's decision to resume COVID-19 vaccine export to have immense positive impact: GAVI | Latest national News at Lokmattimes.com

National :India's decision to resume COVID-19 vaccine export to have immense positive impact: GAVI

India's decision to export the COVID-19 vaccine could have an immense positive impact on health security within India as well as globally, said the global vaccine alliance 'Gavi' on Tuesday. ...

India to procure more than 25 crore Covid vaccine doses per month: government sources - Hindi News | India to procure more than 25 crore Covid vaccine doses per month: government sources | Latest national News at Lokmattimes.com

National :India to procure more than 25 crore Covid vaccine doses per month: government sources

India set a world record by administering 2.5 crore COVID vaccine doses in a single day on Friday. The country's target is to procure more than 25 crore doses per month, said a government source. ...

SII announces strategic partnership with Biocon Biologics - Hindi News | SII announces strategic partnership with Biocon Biologics | Latest national News at Lokmattimes.com

National :SII announces strategic partnership with Biocon Biologics

Hoping to strengthen India's position as a global vaccine and biologics manufacturing powerhouse, COVID-19 vaccine Covishield maker Serum Institute of India (SII) announced a strategic alliance with biopharmaceutical company Biocon Biologics Limited ...

SII paid Rs 3,000 cr for 50% stake in SCHOTT Kaisha - Hindi News | SII paid Rs 3,000 cr for 50% stake in SCHOTT Kaisha | Latest international News at Lokmattimes.com

International :SII paid Rs 3,000 cr for 50% stake in SCHOTT Kaisha

New Delhi, Sep 6 The Serum Institute of India (SII) paid Rs 3,000 crore for a 50 per ... ...

70% of Nepal's population developed Covid antibodies, finds study - Hindi News | 70% of Nepal's population developed Covid antibodies, finds study | Latest health News at Lokmattimes.com

Health :70% of Nepal's population developed Covid antibodies, finds study

Kathmandu, Aug 29 Almost 70 per cent of Nepal's population have developed Covid antibodies, a large-scale seroprevalence study ... ...

SII acquires 50 pc stake in pharma packaging firm Schott Kaisha - Hindi News | SII acquires 50 pc stake in pharma packaging firm Schott Kaisha | Latest national News at Lokmattimes.com

National :SII acquires 50 pc stake in pharma packaging firm Schott Kaisha

Serum Institute of India (SII) acquired a 50 pc stake of SCHOTT Kaisha to become SCHOTT's joint venture partner and secure pharma packaging supply, Serum Institute of India announced on Tuesday. ...

SII acquires 50% stake in SCHOTT Kaisha JV for pharma packaging play - Hindi News | SII acquires 50% stake in SCHOTT Kaisha JV for pharma packaging play | Latest health News at Lokmattimes.com

Health :SII acquires 50% stake in SCHOTT Kaisha JV for pharma packaging play

Pune, Aug 17 The world's largest vaccine maker Serum Institute of India has bought 50 per cent stake ... ...

Mixing two different vaccines of COVID-19 is very risky: Cyrus Poonawalla - Hindi News | Mixing two different vaccines of COVID-19 is very risky: Cyrus Poonawalla | Latest national News at Lokmattimes.com

National :Mixing two different vaccines of COVID-19 is very risky: Cyrus Poonawalla

Mixing two different vaccines of COVID-19 is a very risky decision and it is must be discouraged, said Cyrus Poonawalla, chairman of Serum Institute of India (SII) on Friday. ...